Valuation: Precipio, Inc.

Market Cap 4.09Cr 3.6Cr 3.34Cr 3.07Cr 5.76Cr 396.04Cr 5.87Cr 40Cr 16Cr 193.17Cr 15Cr 15Cr 670.16Cr P/E 2024
-1.89x
P/E 2025 -102x
Enterprise Value 4.19Cr 3.68Cr 3.42Cr 3.15Cr 5.9Cr 405.74Cr 6.01Cr 41Cr 16Cr 197.9Cr 16Cr 15Cr 686.58Cr EV / Sales 2024
0.44x
EV / Sales 2025 1.72x
Free-Float
87.35%
Yield 2024 *
-
Yield 2025 -
1 day-2.56%
1 week-3.38%
Current month-7.59%
1 month-1.38%
3 months-15.35%
6 months-6.80%
Current year-0.44%
1 week 22.51
Extreme 22.51
24.75
1 month 22
Extreme 22
27.13
Current year 19.52
Extreme 19.52
33.63
1 year 13.8
Extreme 13.8
33.63
3 years 3.9
Extreme 3.9
33.63
5 years 3.9
Extreme 3.9
83.4
10 years 3.9
Extreme 3.9
8,448.01
Manager TitleAgeSince
Chief Operating Officer 41 -
Chief Tech/Sci/R&D Officer 42 01/06/2017
Chief Executive Officer 54 28/06/2017
Director TitleAgeSince
Director/Board Member 54 28/06/2017
Director/Board Member 78 26/09/2017
Director/Board Member 67 08/11/2017
Date Insider Type Main position Quantity % Market Cap.
15/07/26 Free

Director

416 0.0233%
15/07/26 Free

Director

520 0.0291%
15/07/26 Free

Director

108 0.0060%
Change 5-day change 1-year change 3-year change Capi.($)
-2.56%-3.38%+55.86%+252.00% 4.09Cr
-2.68%-10.52%+12.53%-39.30% 1.56TCr
+9.95%+6.85%+9.30%+115.26% 178.69Cr
-0.60%-9.10%-37.67%-80.94% 113.06Cr
-2.34%-5.52%-38.70%+10.26% 96Cr
+0.57%-6.27%-29.58%-53.93% 63Cr
+2.48%-10.19%-47.94%-56.93% 52Cr
+0.56%-0.37%+39.40%-53.79% 45Cr
+0.42%-4.94%-57.43%-61.93% 36Cr
+0.14%-4.89%-21.61%-39.26% 34Cr
Average +0.59%-2.37%-11.58%-0.86% 218.44Cr
Weighted average by Cap. -1.15%-7.06%+3.73%-27.60%

Financials

2024 2025
Net sales 1.85Cr 1.63Cr 1.51Cr 1.39Cr 2.61Cr 179.47Cr 2.66Cr 18Cr 7.06Cr 88Cr 6.96Cr 6.81Cr 303.69Cr 2.4Cr 2.12Cr 1.96Cr 1.81Cr 3.39Cr 232.89Cr 3.45Cr 23Cr 9.16Cr 113.6Cr 9.03Cr 8.83Cr 394.1Cr
Net income -42.9L -37.73L -35.05L -32.24L -60.46L -42Cr -61.54L -4.19Cr -1.63Cr -20Cr -1.61Cr -1.58Cr -70Cr -4L -3L -3L -3L -5L -3.52Cr -5L -35.47L -13.83L -1.71Cr -13.63L -13.33L -5.95Cr
Net Debt -1L -1L -1L -1L -2L -1.32Cr -2L -13.29L -5L -64.24L -5L -5L -2.23Cr 10.02L 9L 8L 8L 14.12L 9.7Cr 14.37L 97.9L 38.19L 4.73Cr 37.62L 36.8L 16Cr
Logo Precipio, Inc.
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Employees
66
Date Price Change Volume
23/26/23 $22.88 -2.56% 94,406
22/26/22 $23.48 -0.93% 2,54,918
21/26/21 $23.70 +1.28% 85,145
20/26/20 $23.40 -5.03% 1,09,126
17/26/17 $24.64 +4.05% 1,08,324
  1. Stock Market
  2. Stocks
  3. PRPO Stock